Literature DB >> 15037716

Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation.

Karin Jurkat-Rott1, Frank Lehmann-Horn.   

Abstract

An R83H point mutation in KCNE3-encoded MiRP2 has been reported to cause 2% of all cases of familial periodic paralysis. The authors found MiRP2-R83H in 3 of 321 control subjects and in 5 unaffected related individuals. Provocation of an unaffected carrier with glucose or KCl did not induce weakness. The authors propose that causality criteria for mutations require exclusion of mutations in n = ln(P)/ln(1 - p(1)) ethnically matched control chromosomes (P = acceptable error probability; p(1) = mutation prevalence in patient chromosomes).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037716     DOI: 10.1212/01.wnl.0000119392.29624.88

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

Review 1.  Muscle channelopathies and critical points in functional and genetic studies.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 2.  Diagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre.

Authors:  F Lehmann-Horn; K Jurkat-Rott; R Rüdel
Journal:  Acta Myol       Date:  2008-12

3.  Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family.

Authors:  Qiufen Wang; Mugen Liu; Chunsheng Xu; Zhaohui Tang; Yuhua Liao; Rong Du; Wei Li; Xiaoyan Wu; Xu Wang; Ping Liu; Xianqin Zhang; Jianfang Zhu; Xiang Ren; Tie Ke; Qing Wang; Junguo Yang
Journal:  J Mol Med (Berl)       Date:  2005-02-22       Impact factor: 4.599

4.  A novel mutation in CACNA1S gene associated with hypokalemic periodic paralysis which has a gender difference in the penetrance.

Authors:  Fei-Feng Li; Qian-Qian Li; Zhen-Xuan Tan; Si-Yao Zhang; Ji Liu; Er-ying Zhao; Gui-Chun Yu; Jin Zhou; Li-Ming Zhang; Shu-Lin Liu
Journal:  J Mol Neurosci       Date:  2011-08-16       Impact factor: 3.444

5.  Targeted deletion of Kcne3 impairs skeletal muscle function in mice.

Authors:  Elizabeth C King; Vishal Patel; Marie Anand; Xiaoli Zhao; Shawn M Crump; Zhaoyang Hu; Noah Weisleder; Geoffrey W Abbott
Journal:  FASEB J       Date:  2017-03-29       Impact factor: 5.191

Review 6.  Paroxysmal muscle weakness: the familial periodic paralyses.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  J Neurol       Date:  2006-11-30       Impact factor: 4.849

7.  Deep resequencing of the voltage-gated potassium channel subunit KCNE3 gene in chronic tinnitus.

Authors:  Philipp G Sand; Berthold Langguth; Tobias Kleinjung
Journal:  Behav Brain Funct       Date:  2011-09-07       Impact factor: 3.759

8.  Disruption of the K+ channel beta-subunit KCNE3 reveals an important role in intestinal and tracheal Cl- transport.

Authors:  Patricia Preston; Lena Wartosch; Dorothee Günzel; Michael Fromm; Patthara Kongsuphol; Jiraporn Ousingsawat; Karl Kunzelmann; Jacques Barhanin; Richard Warth; Thomas J Jentsch
Journal:  J Biol Chem       Date:  2010-01-05       Impact factor: 5.157

Review 9.  Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder.

Authors:  Bertrand Fontaine; Emmanuel Fournier; Damien Sternberg; Savine Vicart; Nacira Tabti
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 10.  Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.